Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $840.4300 (-1%) ($840.4300 - $840.4300) on Fri. Dec. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.09% (three month average) | RSI | 72 | Latest Price | $840.4300(-1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(53%) IBB(52%) XLV(50%) SPLV(48%) XLU(45%) | Factors Impacting REGN price | REGN will decline at least -0.545% in a week (0% probabilities). IVW(-41%) ONLN(-38%) USO(-37%) VXX(-36%) EDOC(-36%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.545% (StdDev 1.09%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $833.75(0.8%) | 10 Day Moving Average | $822.32(2.2%) | 20 Day Moving Average | $810.33(3.71%) | To recent high | -1% | To recent low | 8.4% | Market Cap | $89.11b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |